RxSight Inc [RXST] stock is trading at $25.25, down -4.93%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RXST shares have gain 1.32% over the last week, with a monthly amount drifted -10.97%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on December 20, 2024, when Stifel downgraded its rating to a Hold and also revised its price target to $40 from $65. Previously, Wells Fargo downgraded its rating to Equal Weight on December 11, 2024, and dropped its price target to $42. On December 06, 2024, UBS initiated with a Buy rating and assigned a price target of $52 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $72 on October 29, 2024. Needham reiterated its recommendation of a Buy and raised its price target to $66 on August 20, 2024. Needham reiterated a Buy rating for this stock on August 06, 2024, and downed its price target to $54. In a note dated May 07, 2024, BTIG Research reiterated an Buy rating on this stock and boosted its target price from $61 to $72.
RxSight Inc [RXST] stock has fluctuated between $24.09 and $66.54 over the past year. Currently, Wall Street analysts expect the stock to reach $75.25 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $25.25 at the most recent close of the market. An investor can expect a potential return of 198.02% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 139.93M for the trailing twelve months, which represents a growth of 40.71%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.25%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.11 and Total Capital is -0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.76 points at the first support level, and at 24.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 25.99, and for the 2nd resistance point, it is at 26.73.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 11.36. Also, the Quick Ratio is 10.50, while the Cash Ratio stands at 0.65. Considering the valuation of this stock, the price to sales ratio is 7.31, the price to book ratio is 3.63.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
